NLRP3 and chronic obstructive pulmonary disease: ↓ pulmonary oxidative stress, dyspnoea, and IL‐8 levels, ↑ sleep duration and efficacy.↓ airway inflammation by inhibiting the NLRP3 inflammasome and IL‐1β in lungs in COPD mouse model.